Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyrus Chargari

Showing results (61-70 of 379) with videos related to

Pageof 38
Sort By:
Brachytherapy|February 16, 2010
Technical aspects and perspectives of the vaginal mold applicator for brachytherapy of gynecologic malignanciesNicolas Magné, Cyrus Chargari, Nicholas SanFilippo, et al.
British Journal of Neurosurgery|May 23, 2013
Preventing radiotherapy-induced side effects on deep brain stimulators: the need for a multidisciplinary managementJean-Baptiste Guy, Antonin Levy, Nadia Malkoun, et al.
European Journal of Cancer (Oxford, England : 1990)|May 21, 2016
Can immunostimulatory agents enhance the abscopal effect of radiotherapy?Antonin Levy, Cyrus Chargari, Aurelien Marabelle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2011
Whole brain radiotherapy: prognostic factors and results of a radiation boost delivered through a conventional linear acceleratorAvi Assouline, Antonin Levy, Cyrus Chargari, et al.
Investigational New Drugs|December 15, 2010
Further developments for improving response and tolerance to irradiation for advanced renal cancer: concurrent (mTOR) inhibitor RAD001 and helical tomotherapyYoulia M Kirova, Vincent Servois, Cyrus Chargari, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 11, 2007
[Testicular metastasis of prostatic adenocarcinoma: a case report]Olivier Bauduceau, Lionel Vedrine, Cyrus Chargari, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2009
DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgeryChristine Haie-Meder, Cyrus Chargari, Annie Rey, et al.
Investigational New Drugs|January 17, 2012
Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapyCéline Clémenson, Cyrus Chargari, Laurent Désiré, et al.
Endocrine-Related Cancer|July 18, 2008
Reapprasial of the role of endocrine therapy in meningioma managementCyrus Chargari, Lionel Védrine, Oliver Bauduceau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 27, 2010
MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapyChristine Haie-Meder, Cyrus Chargari, Annie Rey, et al.
Pageof 38

Showing results (61-70 of 379) with videos related to

Sort By:
Pageof 38
Brachytherapy|February 16, 2010
Technical aspects and perspectives of the vaginal mold applicator for brachytherapy of gynecologic malignanciesNicolas Magné, Cyrus Chargari, Nicholas SanFilippo, et al.
British Journal of Neurosurgery|May 23, 2013
Preventing radiotherapy-induced side effects on deep brain stimulators: the need for a multidisciplinary managementJean-Baptiste Guy, Antonin Levy, Nadia Malkoun, et al.
European Journal of Cancer (Oxford, England : 1990)|May 21, 2016
Can immunostimulatory agents enhance the abscopal effect of radiotherapy?Antonin Levy, Cyrus Chargari, Aurelien Marabelle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2011
Whole brain radiotherapy: prognostic factors and results of a radiation boost delivered through a conventional linear acceleratorAvi Assouline, Antonin Levy, Cyrus Chargari, et al.
Investigational New Drugs|December 15, 2010
Further developments for improving response and tolerance to irradiation for advanced renal cancer: concurrent (mTOR) inhibitor RAD001 and helical tomotherapyYoulia M Kirova, Vincent Servois, Cyrus Chargari, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 11, 2007
[Testicular metastasis of prostatic adenocarcinoma: a case report]Olivier Bauduceau, Lionel Vedrine, Cyrus Chargari, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2009
DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgeryChristine Haie-Meder, Cyrus Chargari, Annie Rey, et al.
Investigational New Drugs|January 17, 2012
Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapyCéline Clémenson, Cyrus Chargari, Laurent Désiré, et al.
Endocrine-Related Cancer|July 18, 2008
Reapprasial of the role of endocrine therapy in meningioma managementCyrus Chargari, Lionel Védrine, Oliver Bauduceau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 27, 2010
MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapyChristine Haie-Meder, Cyrus Chargari, Annie Rey, et al.
Pageof 38